pH-Responsive Polymeric Vehicles for the Oral Delivery of Hemophiliac Factor Ⅸ

摘要

Oral delivery of factor Ⅸ can be achieved by tailoring biomaterial-based microcarriers to improve protein release and increase bioavailability. Successful outcomes of this work will change hemophilia B treatment by offering a novel safe and needle-free protein replacement therapy with improved global accessibility.